Multiple Myeloma Cancer Stem Cells Decreased with Novel Antibody Medi-551
A preliminary clinical study at Johns Hopkins Kimmel Cancer Center demonstrated that antibody treatment could decrease by half the number of cancer stem cells, which control the progression of cancer in almost all patients suffering from multiple myeloma. The efficiency of the antibody MEDI-551 was studied in 15 patients suffering from…